201 related articles for article (PubMed ID: 34433292)
1. Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation.
Künzel SR; Hoffmann M; Weber S; Künzel K; Kämmerer S; Günscht M; Klapproth E; Rausch JSE; Sadek MS; Kolanowski T; Meyer-Roxlau S; Piorkowski C; Tugtekin SM; Rose-John S; Yin X; Mayr M; Kuhlmann JD; Wimberger P; Grützmann K; Herzog N; Küpper JH; O'Reilly M; Kabir SN; Sommerfeld LC; Guan K; Wielockx B; Fabritz L; Nattel S; Ravens U; Dobrev D; Wagner M; El-Armouche A
Circ Res; 2021 Oct; 129(8):804-820. PubMed ID: 34433292
[TBL] [Abstract][Full Text] [Related]
2. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation.
Hu J; Zhang JJ; Li L; Wang SL; Yang HT; Fan XW; Zhang LM; Hu GL; Fu HX; Song WF; Yan LJ; Liu JJ; Wu JT; Kong B
J Cell Mol Med; 2021 Jul; 25(14):6746-6759. PubMed ID: 34132026
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II confers resistance to apoptosis in cardiac myofibroblasts through the AT1/ERK1/2/RSK1 pathway.
Cai W; Zhong S; Zheng F; Zhang Y; Gao F; Xu H; Cai X; Lan J; Huang D; Shi G
IUBMB Life; 2019 Feb; 71(2):261-276. PubMed ID: 30452117
[TBL] [Abstract][Full Text] [Related]
4. Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient mice.
Newe M; Kant TA; Hoffmann M; Rausch JSE; Winter L; Künzel K; Klapproth E; Günther C; Künzel SR
Naunyn Schmiedebergs Arch Pharmacol; 2021 Nov; 394(11):2233-2244. PubMed ID: 34410453
[TBL] [Abstract][Full Text] [Related]
5. Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype.
Kant TA; Newe M; Winter L; Hoffmann M; Kämmerer S; Klapproth E; Künzel K; Kühnel MP; Neubert L; El-Armouche A; Künzel SR
Cells; 2021 Mar; 10(3):. PubMed ID: 33799608
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression and phosphorylation of Sirt7 activates smad2 and ERK signaling and promotes the cardiac fibrosis differentiation upon angiotensin-II stimulation.
Wang H; Liu S; Liu S; Wei W; Zhou X; Lin F; Wang J; Chen J; Zhang G; Pang Y
PLoS One; 2017; 12(6):e0178530. PubMed ID: 28582407
[TBL] [Abstract][Full Text] [Related]
7. Involvement of ERK1/2 in Cx43 depression induced by macrophage migration inhibitory factor in atrial myocytes.
Li X; Rao F; Deng CY; Wei W; Liu FZ; Yang H; Wang ZY; Kuang SJ; Chen XY; Xue YM; Wu SL
Clin Exp Pharmacol Physiol; 2017 Jul; 44(7):771-778. PubMed ID: 28429502
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 Deficiency Induces Atrial Fibrosis and Increases Susceptibility to Atrial Fibrillation by the STAT3 Signaling Pathway.
Zhang M; Wang H; Bie M; Wang X; Lu K; Xiao H
J Cardiovasc Pharmacol; 2021 Aug; 78(2):175-183. PubMed ID: 34554674
[TBL] [Abstract][Full Text] [Related]
9. Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation.
Fukui A; Takahashi N; Nakada C; Masaki T; Kume O; Shinohara T; Teshima Y; Hara M; Saikawa T
Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):402-9. PubMed ID: 23406575
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.
Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL
Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774
[TBL] [Abstract][Full Text] [Related]
11. Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation.
Campbell HM; Quick AP; Abu-Taha I; Chiang DY; Kramm CF; Word TA; Brandenburg S; Hulsurkar M; Alsina KM; Liu HB; Martin B; Uhlenkamp D; Moore OM; Lahiri SK; Corradini E; Kamler M; Heck AJR; Lehnart SE; Dobrev D; Wehrens XHT
Circulation; 2020 Sep; 142(12):1159-1172. PubMed ID: 32683896
[TBL] [Abstract][Full Text] [Related]
12. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
[TBL] [Abstract][Full Text] [Related]
13. Matricellular Protein Cilp1 Promotes Myocardial Fibrosis in Response to Myocardial Infarction.
Zhang QJ; He Y; Li Y; Shen H; Lin L; Zhu M; Wang Z; Luo X; Hill JA; Cao D; Luo RL; Zou R; McAnally J; Liao J; Bajona P; Zang QS; Yu Y; Liu ZP
Circ Res; 2021 Nov; 129(11):1021-1035. PubMed ID: 34610755
[TBL] [Abstract][Full Text] [Related]
14. Repurposing mesalazine against cardiac fibrosis in vitro.
Hoffmann M; Kant TA; Emig R; Rausch JSE; Newe M; Schubert M; Künzel K; Winter L; Klapproth E; Peyronnet R; Ravens U; El-Armouche A; Künzel SR
Naunyn Schmiedebergs Arch Pharmacol; 2021 Mar; 394(3):533-543. PubMed ID: 33064167
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis.
Molkentin JD; Bugg D; Ghearing N; Dorn LE; Kim P; Sargent MA; Gunaje J; Otsu K; Davis J
Circulation; 2017 Aug; 136(6):549-561. PubMed ID: 28356446
[TBL] [Abstract][Full Text] [Related]
16. Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction.
Ikeda Y; Sato K; Pimentel DR; Sam F; Shaw RJ; Dyck JR; Walsh K
J Biol Chem; 2009 Dec; 284(51):35839-49. PubMed ID: 19828446
[TBL] [Abstract][Full Text] [Related]
17. LIM kinase 1 acts as a profibrotic mediator in permanent atrial fibrillation patients with valvular heart disease.
Chen Q; Gimple RC; Li G; Chen J; Wu H; Li R; Xie J; Xu B
J Biosci; 2019 Mar; 44(1):. PubMed ID: 30837367
[TBL] [Abstract][Full Text] [Related]
18. TNAP is a novel regulator of cardiac fibrosis after myocardial infarction by mediating TGF-β/Smads and ERK1/2 signaling pathways.
Cheng X; Wang L; Wen X; Gao L; Li G; Chang G; Qin S; Zhang D
EBioMedicine; 2021 May; 67():103370. PubMed ID: 33971401
[TBL] [Abstract][Full Text] [Related]
19. Bisphenol A, an environmental estrogen-like toxic chemical, induces cardiac fibrosis by activating the ERK1/2 pathway.
Hu Y; Zhang L; Wu X; Hou L; Li Z; Ju J; Li Q; Qin W; Li J; Zhang Q; Zhou T; Zhang L; Xu C; Fang Z; Zhang Y
Toxicol Lett; 2016 May; 250-251():1-9. PubMed ID: 27025157
[TBL] [Abstract][Full Text] [Related]
20. Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate.
Kunamalla A; Ng J; Parini V; Yoo S; McGee KA; Tomson TT; Gordon D; Thorp EB; Lomasney J; Zhang Q; Shah S; Browne S; Knight BP; Passman R; Goldberger JJ; Aistrup G; Arora R
Circ Res; 2016 Jun; 119(1):69-82. PubMed ID: 27217399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
